Prospects of using phytoadaptogen in the treatment of diffuse stomach cancer.

Autor: Bocharova OA; N. N. Blokhin National Oncological Research Center, Russian Academy of Medical Sciences, Moscow, Russia. planta39@rambler.ru, Davydov MI, Klimenkov AA, Baryshnikov AY, Karpova RV, Chulkova SV, Gorozhanskaya EG, Ilyenko VA
Jazyk: angličtina
Zdroj: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2009 Jul; Vol. 148 (1), pp. 82-5.
DOI: 10.1007/s10517-009-0652-6
Abstrakt: The efficiency of treatment of diffuse stomach cancer can be improved by using a complex phytoadaptogen. In groups receiving phytoadaptogen, the level of tumor marker CA 19-9 decreased and the mean life span of patients increased by 2.5 times. The drug exhibited immunomodulating (including interferonogenic and adhesiogenic), antioxidant, and hormone-modulating effects.
Databáze: MEDLINE